Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Omega-3-6-9 Junior
- Development stage
- Unknown
- Lead developer
- Sarah Keim
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Omega-3-6-9 Junior is a lipid-based nutritional supplement manufactured by Nordic Naturals, containing a specific blend of long-chain polyunsaturated fatty acids (LCPUFAs), including eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and gamma-linolenic acid (GLA). It was investigated in the Preemie Tots pilot study led by Dr. Sarah Keim at Nationwide Children's Hospital to evaluate its effects on development and behavior in toddlers born very preterm (≤29 weeks gestation) who exhibit symptoms of autism spectrum disorder (ASD). The supplement aims to provide essential fatty acids that are critical for brain development and may be deficient in children born prematurely. Clinical findings suggested that supplementation may reduce autism symptoms based on parent reports, with improvements observed in language development and social gesture use.
- Brand names
- Omega-3-6-9 JuniorOmega3-6-9 JuniorOmega 3-6-9 Junior
- Other names
- LCPUFA oil supplementNordic Naturals Omega-3-6-9 Junior
02
Targets
PPARG (Peroxisome proliferator-activated receptor gamma)PPARA (Peroxisome proliferator-activated receptor alpha)
Beyond the preview
Go deeper on Omega-3-6-9 Junior.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omega-3-6-9 Junior.